Credit Agricole’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-80,100
Closed -$191K 1314
2025
Q4
$191K Buy
+80,100
New +$219K ﹤0.01% 1224
2025
Q1
$363K Hold
80,100
﹤0.01% 1059
2024
Q4
$566K Hold
80,100
﹤0.01% 1037
2024
Q3
$652K Hold
80,100
﹤0.01% 904
2024
Q2
$512K Buy
+80,100
New +$514K ﹤0.01% 828

Other funds holding HCAT

Credit Agricole's HCAT Position: Q1 2026 in Review

Credit Agricole sold out of Health Catalyst (HCAT) in Q1 2026, closing a stake of 80,100 shares — an estimated $191K sold.

Credit Agricole first reported a position in HCAT in Q2 2024 and held it in 5 quarters. The position peaked at $652K in Q3 2024. 130 funds tracked by Wall St. Rank hold HCAT as of Q1 2026.

  • Credit Agricole reported no remaining Health Catalyst position as of Q1 2026 after selling out during the quarter.
  • Credit Agricole sold 80,100 Health Catalyst shares in Q1 2026, an estimated $191K.
  • Credit Agricole first reported a position in Health Catalyst in Q2 2024 and held it in 5 quarters.
  • Credit Agricole's Health Catalyst position peaked at $652K in Q3 2024.
  • 130 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2026.

Based on Credit Agricole's 13F filing for Q1 2026, filed 15 May 2026.